Pantherna Therapeutics
Key Facts
| Invested since | 2019 |
| Based in | Hennigsdorf |
About the company
Pantherna Therapeutics is a wholly owned subsidiary of T-CURX GmbH, Würzburg, and based in Hennigsdorf (Brandenburg), Germany . Pantherna’s proprietary platform focuses on the development of advanced lipid nanoparticle (PTX_LNP) technology for targeted and cell-selective delivery of nucleic acids, including its propriertary PTXmRNA molecules. Pantherna´s technology offers solutions for next-generation cell engineering approaches, supporting both ex vivo and in vivo applications, such as emerging in vivo CAR-T strategies, opening new avenues for innovative therapies in oncology and beyond.
Do you want to
know more about this company?
Pantherna Therapeutics in the news
zum Artikel
T-CURX acquires Pantherna Therapeutics to accelerate clinical translation of its non-viral in vivo CAR-T strategies
zum Artikel
Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs
zum Artikel
“First-in-Class“ mRNA-therapeutics for vascular diseases: Pantherna Therapeutics receives 7-digit investment
More startups from Life Sciences
Resolve Biosciences is creating solutions which offer the power of Molecular Cartography enabling scientists to gain valuable insights at subcellular resolution, across vast numbers of biomolecules (RNA, DNA, proteins) to …
to Resolve Biosciences
Clee Medical SA is a Swiss medical technology company based in Geneva developing minimally invasive neurotechnology solutions. Its flagship platform, Neuro Access, combines ultra-high-resolution real-time intraoperative Optical Coherence Tomography imaging …
to Clee Medical
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Our G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only …
to Akribion Therapeutics
Exit
PreOmics develops and provides innovative technologies for customers around the world for mass spectrometry (MS) – based proteomics using cutting-edge technologies to support researchers in their protein analysis needs.
to PreOmics
Symphera is a Munich-based startup that is revolutionizing laparoscopic surgery with an innovative system designed to eliminate the need for manual instrument changes. Founded in 2023, Symphera was incubated at …
to Symphera
Mbiomics is a Munich based microbiome startup company which was founded by Dr. Laura Figulla (CEO), Dr. Johannes Wöhrstein (CTO), and Dr. Markus Rinecker (CMO) in 2020. With its proprietary …
to mbiomics
TECregen is pioneering thymus rejuvenation to address conditions driven by impaired T-cell responses. The company’s innovative approach focuses on revitalizing and expanding thymic epithelial cells (TECs) to replenish T cells …
to TECregen
IOP GmbH will initiate a paradigm chance in glaucoma therapy by its products for telemetric, 24 hour monitoring of intraocular pressure, allowing personalized patient management.
to Implandata Ophthalmic Products
Nuuron was founded by Fabian Queisner and Dr. Markus Müschenich. The scientific director is Priv.-Doz. Dr. Julian Keil. The Nuuron team consists of experts in the fields of neuroscience, medicine, …
to Nuuron
Optimization of atrial fibrillation therapy via precise, non-thermal pulsed field ablation
to Argá Medtech
Exit
GME German Medical Engineering develops and markets a new generation of laser and lightsystems (small, light weight, modular) for the use in cosmetic and medical dermatology.
to GME
Zedira is a clinical stage biotech company specialized in the enzyme class of transglutaminases. Zedira performs drug discovery (e.g. celiac disease, diabetic nephropathy and thromboprophylaxis) and markets specialty reagents for …
to Zedira